Not yet recruiting
Efficacy and Resistant Mechanism of Eribulin and Bevacizumab for Advanced HER2 Negative Breast Cancer
NCT06539559
- Conditions
- Bevacizumab, Breast Diseases, Breast Neoplasms, +9 more
- Locations
-
- Beijing Chaoyang District San Huan Cancer Hospital Beijing, Beijing Municipality, China
- Cancer Hospital of HuanXing ChaoYang District Beijing, Beijing Municipality, China
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China